Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?-Reference-Cited by-同舟云学术

Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?

Published:2017-12 Issue:49 Volume:35 Page:6793-6797
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Giersing Birgitte K.,Kahn Anna-Lea^ORCID,Jarrahian Courtney,Mvundura Mercy,Rodriguez Carmen,Okayasu Hiromasa,Zehrung Darin

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Protecting the world’s children: the story of WHO’s immunization programme;Bland;World Health Forum,1998

2. World Health Organization, Immunization, Vaccines and Biologicals. WHO recommendations for routine immunization – summary tables; September 2016. [accessed 17.02.02].

3. Global routine vaccination coverage, 2015;Casey;Wkly Epidemiol Rec,2016

4. Costs of vaccine programs across 94 low- and middle-income countries;Portnoy;Vaccine,2015

5. Desirable attributes of vaccines for deployment in low-resource settings;Chen;J Pharm Sci,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OPTIMIZING CARBON EMISSIONS AND COST IN VACCINE TRANSPORTATION: DESIGNING A TYPE-2 FUZZY ENVIRONMENT MODEL FOR EFFECTIVE VACCINE DISTRIBUTION;INT J IND ENG-THEORY;2023

2. Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries;PLOS ONE;2022-06-23

3. Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines;PLOS Global Public Health;2022-05-03

4. Optimization methods for large-scale vaccine supply chains: a rapid review;Annals of Operations Research;2022-04-30

5. Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination;Drug Delivery and Translational Research;2022-02-24